The Impact of Pharmacist-led Mobile Application on Adherence in Chronic Kidney Disease Patients
The Impact of Pharmacist - Led Mobile Application on Medication Adherence and Efficacy in Chronic Kidney Disease Patients
1 other identifier
interventional
86
1 country
1
Brief Summary
The aim of the study is to assess the impact of pharmacist led mobile application on adherence and efficacy of medication in chronic kidney disease patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 24, 2021
CompletedFirst Posted
Study publicly available on registry
December 23, 2021
CompletedStudy Start
First participant enrolled
September 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 5, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 5, 2023
CompletedFebruary 9, 2024
February 1, 2024
1.2 years
November 24, 2021
February 7, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in medication adherence
Using a medication adherence questionnaire.
Change from baseline at 3 months
Secondary Outcomes (4)
Change in estimated glomerular filtration rate/ creatinine clearance
Change from baseline at 3 months
Change in systolic and diastolic blood pressure
Change from baseline at 3 months
Change in HbA1c
Change from baseline at 3 months
Change in mobile application usability and acceptability by patients
Change from baseline at 3 months
Study Arms (2)
Control Group
NO INTERVENTIONControl group will be provided with usual care. Intervention group will be provided in addition to the usual care, with an access to the previously described mobile application
Intervention Group
EXPERIMENTALIntervention group will be provided in addition to the usual care, with an access to the mobile application
Interventions
mobile phone applications directed to chronic kidney disease patients to improve their medication.
Eligibility Criteria
You may qualify if:
- Stages 2-5 of chronic kidney disease
- Literate
- Ownership of android smart phone compatible with the application
- Poly-pharmacy
You may not qualify if:
- On dialysis due to loss of kidney function
- Pregnancy due to altered physiology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Private Clinic
Cairo, Egypt
Related Publications (1)
Gamal S, Elseasi AMA, Sabry NA, Farid SF. Impact of pharmacist led mobile application on medication adherence and efficacy in chronic kidney disease. NPJ Digit Med. 2025 May 30;8(1):325. doi: 10.1038/s41746-025-01742-8.
PMID: 40447835DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shaza Gamal, Bsc
Teaching Assistant
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Teaching Assistant
Study Record Dates
First Submitted
November 24, 2021
First Posted
December 23, 2021
Study Start
September 17, 2022
Primary Completion
December 5, 2023
Study Completion
December 5, 2023
Last Updated
February 9, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share